EP3248544A4 - Device for measuring concentration of substance in blood, and method for measuring concentration of substance in blood - Google Patents

Device for measuring concentration of substance in blood, and method for measuring concentration of substance in blood Download PDF

Info

Publication number
EP3248544A4
EP3248544A4 EP16740127.2A EP16740127A EP3248544A4 EP 3248544 A4 EP3248544 A4 EP 3248544A4 EP 16740127 A EP16740127 A EP 16740127A EP 3248544 A4 EP3248544 A4 EP 3248544A4
Authority
EP
European Patent Office
Prior art keywords
blood
substance
measuring concentration
concentration
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP16740127.2A
Other languages
German (de)
French (fr)
Other versions
EP3248544A1 (en
EP3248544B1 (en
Inventor
Koichi Yamakawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institutes For Quantum Science and Technology
Original Assignee
National Institutes For Quantum Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Institutes For Quantum Science and Technology filed Critical National Institutes For Quantum Science and Technology
Publication of EP3248544A1 publication Critical patent/EP3248544A1/en
Publication of EP3248544A4 publication Critical patent/EP3248544A4/en
Application granted granted Critical
Publication of EP3248544B1 publication Critical patent/EP3248544B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/55—Specular reflectivity
    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/35—Non-linear optics
    • G02F1/3501—Constructional details or arrangements of non-linear optical devices, e.g. shape of non-linear crystals
    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/35—Non-linear optics
    • G02F1/39—Non-linear optics for parametric generation or amplification of light, infrared or ultraviolet waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/30—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure
    • A61B2090/306—Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure using optical fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36—Image-producing devices or illumination devices not otherwise provided for
    • A61B90/361—Image-producing devices, e.g. surgical cameras
    • A61B2090/3614—Image-producing devices, e.g. surgical cameras using optical fibre
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02—Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0233—Special features of optical sensors or probes classified in A61B5/00
    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/35—Non-linear optics
    • G02F1/3501—Constructional details or arrangements of non-linear optical devices, e.g. shape of non-linear crystals
    • G02F1/3507—Arrangements comprising two or more nonlinear optical devices
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01S—DEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES OTHER THAN OPTICAL
    • H01S3/00—Lasers, i.e. devices using stimulated emission of electromagnetic radiation in the infrared, visible or ultraviolet wave range
    • H01S3/14—Lasers, i.e. devices using stimulated emission of electromagnetic radiation in the infrared, visible or ultraviolet wave range characterised by the material used as the active medium
    • H01S3/16—Solid materials
    • H01S3/1601—Solid materials characterised by an active (lasing) ion
    • H01S3/1603—Solid materials characterised by an active (lasing) ion rare earth
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01S—DEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES OTHER THAN OPTICAL
    • H01S3/00—Lasers, i.e. devices using stimulated emission of electromagnetic radiation in the infrared, visible or ultraviolet wave range
    • H01S3/14—Lasers, i.e. devices using stimulated emission of electromagnetic radiation in the infrared, visible or ultraviolet wave range characterised by the material used as the active medium
    • H01S3/16—Solid materials
    • H01S3/163—Solid materials characterised by a crystal matrix
    • H01S3/164—Solid materials characterised by a crystal matrix garnet
    • H01S3/1643—YAG
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01S—DEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES OTHER THAN OPTICAL
    • H01S3/00—Lasers, i.e. devices using stimulated emission of electromagnetic radiation in the infrared, visible or ultraviolet wave range
    • H01S3/14—Lasers, i.e. devices using stimulated emission of electromagnetic radiation in the infrared, visible or ultraviolet wave range characterised by the material used as the active medium
    • H01S3/22—Gases
    • H01S3/223—Gases the active gas being polyatomic, i.e. containing two or more atoms
    • H01S3/2232—Carbon dioxide (CO2) or monoxide [CO]

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nonlinear Science (AREA)
  • Optics & Photonics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
EP16740127.2A 2015-01-21 2016-01-19 Device for measuring concentration of substance in blood, and method for measuring concentration of substance in blood Active EP3248544B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015009504 2015-01-21
PCT/JP2016/051339 WO2016117520A1 (en) 2015-01-21 2016-01-19 Device for measuring concentration of substance in blood, and method for measuring concentration of substance in blood

Publications (3)

Publication Number Publication Date
EP3248544A1 EP3248544A1 (en) 2017-11-29
EP3248544A4 true EP3248544A4 (en) 2018-09-05
EP3248544B1 EP3248544B1 (en) 2021-12-08

Family

ID=56417064

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16740127.2A Active EP3248544B1 (en) 2015-01-21 2016-01-19 Device for measuring concentration of substance in blood, and method for measuring concentration of substance in blood

Country Status (5)

Country Link
US (2) US10806385B2 (en)
EP (1) EP3248544B1 (en)
JP (3) JP6415606B2 (en)
CN (1) CN107427266B (en)
WO (1) WO2016117520A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118099918A (en) * 2017-09-05 2024-05-28 国立研究开发法人量子科学技术研究开发机构 Light source and measuring device
EP3477278B1 (en) * 2017-10-27 2020-04-22 Humboldt-Universität zu Berlin Photoacoustics method with a measuring light comprising a predetermined wavelength range for determining the properties of an inhomogeneous sample
WO2019110084A1 (en) * 2017-12-04 2019-06-13 Diamontech Gmbh Device and method for analysing a substance
US20210076991A1 (en) * 2018-01-16 2021-03-18 The Regents Of The University Of California In-situ sweat rate monitoring for normalization of sweat analyte concentrations
CN112384786B (en) * 2018-05-09 2024-08-23 国立研究开发法人量子科学技术研究开发机构 Tissue identification device, tissue identification system, tissue identification method and recording medium
CN110514617A (en) * 2018-05-22 2019-11-29 泰科电子(上海)有限公司 Concentration detection device, concentration monitoring device and solar water heater
JP7080480B2 (en) * 2018-07-19 2022-06-06 有限会社ティ・エス・イー Non-invasive blood sugar meter
WO2020017028A1 (en) * 2018-07-20 2020-01-23 桐生電子開発合同会社 Nondestructive inspection device
WO2020121073A1 (en) * 2018-12-14 2020-06-18 Ecole Polytechnique Federale De Lausanne (Epfl) Non-invasive glucose sensor
WO2020130571A1 (en) * 2018-12-19 2020-06-25 전자부품연구원 Non-invasive blood testing device and method
KR102727114B1 (en) * 2019-02-01 2024-11-06 현대자동차주식회사 Non-invasive optical internal substance detector
KR102765475B1 (en) 2019-04-10 2025-02-07 삼성전자주식회사 Apparatus and method for estimating bio-information
CN112641443A (en) * 2019-10-12 2021-04-13 潍坊学院 Device for nondestructive testing of glucose in subcutaneous tissue fluid
JP7439456B2 (en) * 2019-10-28 2024-02-28 株式会社リコー Biological information measuring device and biological information measuring method
DE112020006830T5 (en) * 2020-03-04 2022-12-15 Mitsubishi Electric Corporation MEASURING DEVICE FOR BIOLOGICAL COMPONENTS
JP7729075B2 (en) * 2020-07-30 2025-08-26 株式会社リコー Measuring equipment
WO2022023846A1 (en) * 2020-07-30 2022-02-03 Ricoh Company, Ltd. Measuring apparatus
JP7620337B2 (en) * 2020-09-30 2025-01-23 ライトタッチテクノロジー株式会社 Blood substance concentration measuring device and blood substance concentration measuring method
CN112683851A (en) * 2021-03-22 2021-04-20 宁波普瑞柏生物技术股份有限公司 Protein concentration detection and analysis method, device and application thereof
KR102511907B1 (en) * 2021-05-26 2023-03-20 건국대학교 글로컬산학협력단 Non-invasive biomaterial sugar concentration measurement system and method using optical module
CN113675719A (en) * 2021-07-16 2021-11-19 西安电子科技大学 A tunable long-wave mid-infrared ultrafast laser light source device
JP7541301B2 (en) * 2021-08-25 2024-08-28 ライトタッチテクノロジー株式会社 Blood substance concentration measuring device, blood substance concentration measuring method and program
DE102021132135A1 (en) * 2021-12-07 2023-06-07 OSRAM Opto Semiconductors Gesellschaft mit beschränkter Haftung PROCEDURE FOR DETERMINING A SUBSTANCE CONCENTRATION AND DETECTOR ARRANGEMENT
WO2023157164A1 (en) * 2022-02-17 2023-08-24 三菱電機株式会社 Non-invasive substance analysis device
WO2023167804A1 (en) 2022-03-01 2023-09-07 Illumina, Inc. Analog circuit to compensate bias offset in amplifier array
EP4403107A4 (en) * 2022-04-06 2025-02-26 Light Touch Technology Incorporated BLOOD SUBSTANCE CONCENTRATION MEASURING DEVICE, BLOOD SUBSTANCE CONCENTRATION MEASURING METHOD, AND PROGRAM
EP4364660A4 (en) * 2022-09-17 2025-02-26 Light Touch Technology Incorporated BLOOD SUBSTANCE CONCENTRATION MEASURING DEVICE, BLOOD SUBSTANCE CONCENTRATION MEASURING METHOD, AND PROGRAM
JP2024112539A (en) 2023-02-08 2024-08-21 株式会社東芝 Sensing system and reflective optical element
WO2025079663A1 (en) 2023-10-11 2025-04-17 ライトタッチテクノロジー株式会社 Blood substance concentration measurement device, blood substance concentration measurement method, and program

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169676A (en) * 1976-02-20 1979-10-02 Nils Kaiser Method for determining the contents of metabolic products in the blood
JPH11178799A (en) * 1997-12-22 1999-07-06 Matsushita Electric Works Ltd Vital method and device for analyzing superficial tissue of organism
US20040024541A1 (en) * 2001-08-28 2004-02-05 Shinji Uchida Apparatus for measuring information on particular component
US20070213607A1 (en) * 2006-03-07 2007-09-13 Andreas Mandelis Non-invasive biothermophotonic sensor for blood glucose monitoring
US20120088486A1 (en) * 2009-04-07 2012-04-12 Messerchmidt Robert G Peri-critical reflection spectroscopy devices, systems, and methods

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5483474A (en) 1977-12-15 1979-07-03 Citizen Watch Co Ltd Wristwatch with pulsimeter
US4259963A (en) 1979-07-03 1981-04-07 Albert Huch Multi-purpose transducer for transcutaneous blood measurements
US5370114A (en) * 1992-03-12 1994-12-06 Wong; Jacob Y. Non-invasive blood chemistry measurement by stimulated infrared relaxation emission
US6040578A (en) 1996-02-02 2000-03-21 Instrumentation Metrics, Inc. Method and apparatus for multi-spectral analysis of organic blood analytes in noninvasive infrared spectroscopy
US5666956A (en) 1996-05-20 1997-09-16 Buchert; Janusz Michal Instrument and method for non-invasive monitoring of human tissue analyte by measuring the body's infrared radiation
CN1117548C (en) * 1998-06-09 2003-08-13 徐州医学院 Woundless blood sugar measuring apparatus
US6748250B1 (en) 2001-04-27 2004-06-08 Medoptix, Inc. Method and system of monitoring a patient
EP1646312A1 (en) * 2003-07-09 2006-04-19 Glucon Inc. Wearable glucometer
JP4363130B2 (en) * 2003-09-04 2009-11-11 パナソニック電工株式会社 Optical blood glucose level pickup
JP4362075B2 (en) * 2004-02-09 2009-11-11 Ｈｏｙａ株式会社 binoculars
WO2005107579A1 (en) * 2004-05-11 2005-11-17 Koninklijke Philips Electronics N.V. Measurement head for non-invasive blood analysis
WO2005115244A1 (en) 2004-05-26 2005-12-08 Matsushita Electric Industrial Co., Ltd. Optical element for measuring bioinformation and bioinformation measuring device
EP1754443A4 (en) 2004-06-10 2008-10-22 Matsushita Electric Industrial Co Ltd LIVING ORGANISM INFORMATION MEASURING INSTRUMENT, STANDARD ELEMENT, AND METHOD FOR USING LIVING ORGANISM INFORMATION MEASURING INSTRUMENT
AU2005262444A1 (en) * 2004-07-01 2006-01-19 Vivomedical, Inc. Non-invasive glucose measurement
US20080068592A1 (en) 2004-11-12 2008-03-20 Shinji Uchida Optical Element for Measuring Biological Information and Biological Information Measuring Device Using the Optical Element
GB0501826D0 (en) * 2005-01-28 2005-03-09 Melys Diagnostics Ltd Apparatus for measurement of analyte concentration
WO2006132218A1 (en) 2005-06-07 2006-12-14 Omron Healthcare Co., Ltd. Sensor for measuring biological component
US8140139B2 (en) 2005-06-14 2012-03-20 Dominion Assets, Llc Method and apparatus for the non-invasive sensing of glucose in a human subject
US20060281982A1 (en) 2005-06-14 2006-12-14 Diasense, Inc. Method and apparatus for the non-invasive sensing of glucose in a human subject
CN101263388A (en) * 2005-06-14 2008-09-10 道明资产公司 Method and apparatus for the non-invasive detection of glucose in a human subject
US20070093702A1 (en) * 2005-10-26 2007-04-26 Skyline Biomedical, Inc. Apparatus and method for non-invasive and minimally-invasive sensing of parameters relating to blood
WO2007141859A1 (en) * 2006-06-08 2007-12-13 Omron Healthcare Co., Ltd. Biological component measurement device capable of accurately noninvasively measuring biological component
DE102006036920B3 (en) * 2006-08-04 2007-11-29 Nirlus Engineering Ag Measuring glucose concentration in pulsating blood involves determining concentration in first measurement cycle, repeating, measuring transmission, scattering for near infrared wavelengths, computing indicator value, comparing with table
JP4960040B2 (en) * 2006-08-11 2012-06-27 株式会社アドバンテスト Light generation device and terahertz light generation device including the device
JP5243719B2 (en) * 2006-09-25 2013-07-24 パナソニック株式会社 Biological signal measuring tool and biological signal measuring method using the same
JP2008086705A (en) 2006-10-05 2008-04-17 Sanyo Electric Co Ltd Measurement assisting material, and optical measuring method using the same
JP4914916B2 (en) 2007-03-20 2012-04-11 パイオニア株式会社 Biological information measuring device
US8285010B2 (en) 2007-03-21 2012-10-09 Lumidigm, Inc. Biometrics based on locally consistent features
JP2012191969A (en) 2011-03-14 2012-10-11 Shinshu Univ Biological information measuring apparatus
TWI519277B (en) * 2011-03-15 2016-02-01 明達醫學科技股份有限公司 Skin optical diagnosing apparatus and operating method thereof
JP2012194451A (en) * 2011-03-17 2012-10-11 Nec Corp Lock mechanism of optical module
DE102011051949B4 (en) 2011-07-19 2017-05-18 Leica Microsystems Cms Gmbh Changing device for a microscope
CN103096225B (en) * 2011-11-03 2018-05-18 北京美尔斯通科技发展股份有限公司 Bone-conduction microphone
CN202446185U (en) * 2012-01-09 2012-09-26 陈黎敏 Protective liner of air pressure tourniquet
WO2013105519A1 (en) 2012-01-13 2013-07-18 独立行政法人放射線医学総合研究所 Radioactive substance detection device, radiation source location visibility system, and radioactive substance detection method
WO2014011159A1 (en) * 2012-07-10 2014-01-16 Draeger Medical Systems, Inc. Medical sensors with placement sensing technology
JP6333257B2 (en) 2012-08-30 2018-05-30 アイティーアイ・スコットランド ‐ スコティッシュ・エンタープライズＩｔｉ Ｓｃｏｔｌａｎｄ ‐ Ｓｃｏｔｔｉｓｈ Ｅｎｔｅｒｐｒｉｓｅ Long-wavelength infrared detection and image processing using a long-wavelength infrared light source
CN202932921U (en) * 2012-11-12 2013-05-15 刘海艳 Safe anti-pricking trace blood collector for clinical laboratories
TWI609172B (en) * 2012-11-13 2017-12-21 唯亞威方案公司 Portable spectrometer
CN103675266A (en) * 2013-11-14 2014-03-26 成都领御生物技术有限公司 Test strip card based on quantum dot labeling
CN104269680A (en) * 2014-10-14 2015-01-07 安徽理工大学 Electric-shock-prevention safe socket

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169676A (en) * 1976-02-20 1979-10-02 Nils Kaiser Method for determining the contents of metabolic products in the blood
JPH11178799A (en) * 1997-12-22 1999-07-06 Matsushita Electric Works Ltd Vital method and device for analyzing superficial tissue of organism
US20040024541A1 (en) * 2001-08-28 2004-02-05 Shinji Uchida Apparatus for measuring information on particular component
US20070213607A1 (en) * 2006-03-07 2007-09-13 Andreas Mandelis Non-invasive biothermophotonic sensor for blood glucose monitoring
US20120088486A1 (en) * 2009-04-07 2012-04-12 Messerchmidt Robert G Peri-critical reflection spectroscopy devices, systems, and methods

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
K. L. VODOPYANOV ET AL: "Grating tunable 4 - 14 m GaAs optical parametric oscillator pumped at 3 m", OPTICS EXPRESS, vol. 22, no. 4, 14 February 2014 (2014-02-14), pages 4131, XP055496459, DOI: 10.1364/OE.22.004131 *
MARTINA MEINKE ET AL: "Two-wavelength carbon dioxide laser application for in-vitro blood glucose measurements", INTERNATIONAL SOCIETY FOR OPTICAL ENGINEERING, vol. 13, no. 1, 1 January 2008 (2008-01-01), PO Box 10 Bellingham WA 98227-0010 USA, pages 014021 - 1, XP055496184, ISSN: 1083-3668, DOI: 10.1117/1.2870093 *
See also references of WO2016117520A1 *
SONGLIN YU ET AL: "In vitro glucose measurement using tunable mid-infrared laser spectroscopy combined with fiber-optic sensor", BIOMEDICAL OPTICS EXPRESS, vol. 5, no. 1, 17 December 2013 (2013-12-17), United States, pages 275, XP055467036, ISSN: 2156-7085, DOI: 10.1364/BOE.5.000275 *

Also Published As

Publication number Publication date
EP3248544A1 (en) 2017-11-29
CN107427266B (en) 2021-12-03
HK1243902A1 (en) 2018-07-27
WO2016117520A1 (en) 2016-07-28
US20210038125A1 (en) 2021-02-11
JP2018199080A (en) 2018-12-20
JP6415606B2 (en) 2018-10-31
EP3248544B1 (en) 2021-12-08
US20180000386A1 (en) 2018-01-04
JP2021037321A (en) 2021-03-11
US10806385B2 (en) 2020-10-20
US11412963B2 (en) 2022-08-16
JPWO2016117520A1 (en) 2017-10-26
CN107427266A (en) 2017-12-01

Similar Documents

Publication Publication Date Title
EP3248544A4 (en) Device for measuring concentration of substance in blood, and method for measuring concentration of substance in blood
ZA201806045B (en) Apparatus for measuring the concentration of target substances in blood
EP3001196B8 (en) Blood testing system and method
SG10202104563UA (en) Device and system for analyzing a sample, particularly blood, as well as methods of using the same
EP3269305A4 (en) Non-invasive blood glucose level measurement method and non-invasive blood glucose level measurement device
EP3212085A4 (en) Glucose measuring apparatus and method
EP3169228A4 (en) Device and method suitable for monitoring arterial blood in body part
EP3127480A4 (en) Biological measurement apparatus and biological measurement method
GB201503805D0 (en) Blood analysis apparatus and method
EP3140645B8 (en) Gas component concentration measurement device and method for gas component concentration measurement
EP3294132A4 (en) Blood glucose measurement apparatus and blood glucose measurement method thereof
EP3100683A4 (en) Photoacoustic signal-processing device, photoacoustic signal-processing system, and photoacoustic signal-processing method
EP3360469A4 (en) Apparatus for measuring blood pressure, and method for measuring blood pressure by using same
EP3200118A4 (en) Sample traceability device and method for medical research and/or diagnosis
EP3217877A4 (en) Device and method for measuring blood oxygen level and/or detecting brain hematoma
EP3133390A4 (en) Blood state analysis device, blood state analysis system, blood state analysis method, and program
EP3095386A4 (en) Photoacoustic measurement apparatus and signal-processing device and signal-processing method used in same
EP3139151A4 (en) Oil concentration measurement device and oil concentration measurement method
EP3183361A4 (en) Device, system and method for non-invasively measuring blood glucose
EP3285066A4 (en) METHOD OF MEASURING pH OF ANALYTE SOLUTION, AND pH MEASURING DEVICE
EP3238622A4 (en) Method for noninvasively determining blood glucose concentration
EP3312584A4 (en) Continuous measurement method for hydrogen gas concentration and hydrogen gas concentration measurement device used in same
LT3160645T (en) Device and method for determination of an analyte in blood
EP3207374A4 (en) Method and system for determining the concentration of an analyte in a fluid sample
EP3149461A4 (en) Active, variable sample concentration method and apparatus for sub-ppb measurements and exemplary x-ray analysis applications thereof

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20170717

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 5/1455 20060101AFI20180417BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20180808

RIC1 Information provided on ipc code assigned before grant

Ipc: A61B 5/1455 20060101AFI20180802BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20190424

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20210622

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NATIONAL INSTITUTES FOR QUANTUM SCIENCE AND TECHNOLOGY

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1453143

Country of ref document: AT

Kind code of ref document: T

Effective date: 20211215

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602016067122

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20211208

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220308

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1453143

Country of ref document: AT

Kind code of ref document: T

Effective date: 20211208

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220308

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220309

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220408

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602016067122

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220408

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20220131

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220119

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

26N No opposition filed

Effective date: 20220909

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20220308

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220131

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220119

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220308

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20160119

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211208

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20251222

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20251224

Year of fee payment: 11